Hypouricemic Effect of Ethanol Extract of Aster glehni Leaves in Potassium Oxonate-Induced Hyperuricemic Rats
Clinical Nutrition Research
;
: 126-135, 2018.
Article
in English
| WPRIM
| ID: wpr-713977
ABSTRACT
The prevalence of gout is increasing worldwide, and control of serum uric acid level has been regarded as one of the therapeutic methods for gout. Inhibition of xanthine oxidase (XO) activity which can oxidize hypoxanthine to uric acid has been commonly proposed to decrease serum uric acid level. The aim of this study was to demonstrate the hypouricemic effect of ethanol extract of Aster glehni leaves (EAG) by in vitro and in vivo study in potassium oxonate (PO)-induced hyperuricemic rats. EAG possessed 132.5 ± 6.8 mg QE/g of total flavonoid and showed antioxidant activity. EAG showed in vitro and in vivo inhibitory activity against XO and significantly decreased serum uric acid level in PO-induced hyperuricemic rats without liver toxicity. These results show that EAG significantly attenuates hyperuricemia by inhibiting XO activity, which resulted in the decrease of serum uric acid level. Therefore, EAG might possess a potential therapeutic ability for improving gout.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Potassium
/
Uric Acid
/
Xanthine Oxidase
/
In Vitro Techniques
/
Prevalence
/
Hypoxanthine
/
Hyperuricemia
/
Ethanol
/
Gout
/
Liver
Type of study:
Prevalence study
Limits:
Animals
Language:
English
Journal:
Clinical Nutrition Research
Year:
2018
Type:
Article
Similar
MEDLINE
...
LILACS
LIS